October 20, 2026 10:07 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Operation completed’: Tiger Shroff shooters allegedly alerted handlers after firing, probe reveals | 'I don't mind saying sorry 1,000 times': Sonu Nigam apologises to Kannadigas over ‘Pahalgam’ remark amid concert ban demand | After Vijay, is Dhanush eyeing politics? TVK calls Thalapathy an inspiration | Trump Says Paris Will Become ‘Muslim City Very Soon’, Blames Macron’s Immigration Policies | Four killed in fresh Manipur violence as protesters take bodies to Chief Minister’s residence | Tiger Shroff firing: Three accused arrested on train in Rajasthan, suspected Bishnoi gang link emerges | 'Internet access a fundamental right for children': SC rejects age-based 'blanket' ban | 'We will fight our own government': RG Kar victim's father threatens fresh protest after Sandip Ghosh gets bail | RG Kar shocker: Sandip Ghosh gets bail as only 7 of 147 witnesses examined, junior doctor blasts CBI | Trump waives Russia-related sanctions

Dahej plant of Torrent Pharma receives USFDA approval

| | Mar 18, 2016, at 09:20 pm
Ahmedabad/Mumbai, Mar 18 (IBNS) Torrent Pharma, a leading Indian pharma company, informed on Friday that it has obtained the Establishment Inspection Report from the U.S. Food and Drug Administration (USFDA) for its plant located at Dahej SEZ, Gujarat.
The company had set up the plant mainly to cater to the regulated international markets such as US, Germany, Brazil, etc.
 
Prior to the US approval, the plant had received approval from EU Germany.
 
The Dahej plant is spread across 70 acres of land with a built up area of about 97000 sq meter. Phase 1 has an installed capacity to manufacture 7,500 million tablets/capsules and 25 MT API  per annum. 
 
The company has said that construction of Phase 2 will commence soon. After commission, the total capacity will increase to manufacture of 14,000 million tablets/capsules and 80 MT API  per annum.
 
In their filing with the  National Stock Exchang, the company has said that with the approval of the Dahej plant, three of its five plants have received USFDA approval.
 
The other two plants are located at Indrad (Gujarat) and Pithampur, Indore (Madhya Pradesh).
 
The company's share price moved up during trading hours on Friday following the news of the approval
 
Torrent Pharma is a flagship company of the Torrent Group.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.